Sign up for your FREE email newsletter  +


Clariant opens biotech centre in Planegg

Unit will focus on the development of sustainable biobased products and processes in the ares of chemicals and biofuels

Design and Build | Europe | Sustainability | R and D | Biotechnology

Siegfried acquires three BASF sites

Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy

Design and Build | Europe | Finance

Choosing the right CMO for outsourced work with HPAPIs

To meet growing demand for highly potent drugs, pharma companies must either face a large investment or partner with an experienced CMO. Ash Stevens says CMOs with demonstrated expertise should be at the top of the list – but what else should they offer?

Ingredients | North America

MSF urges India to protect affordable medicines for millions

Organisation highlights access campaign at Obama-Modi meeting in New York

North America | Regulatory | Asia

Ethypharm acquires DB Ashbourne in the UK

Acquisition will generate a turnover of more than €240m for Ethypharm

Europe | Therapeutic Sector | Finance

Healthy growth despite stiff competition

Despite pressure on costs, the demand for outsourced services continues to grow, especially in the biotech sector, says Guy Tiene, That’s Nice Director of Strategic Content

R and D

Merck opens €17m Innovation Centre in Darmstadt, Germany

Will support ideas from staff as well as from external innovators in the healthcare and life science sectors

Europe | R and D

Designer pills and smart capsules that can deliver

Oral delivery of drugs remains a preferred route, and innovation in this field is at its most creative. Dr Sarah Houlton looks at some of the interesting options under development

Drug Delivery | Biotechnology

Johnson Matthey acquires Pharmorphix

Cambridge firm provides solid form services that are critical to successful drug discovery and development

Europe | R and D | Finance

Future drug success is all in the delivery

Today, the mode of delivery can play a huge part in drug choice and success, thus new delivery technologies are proving to be a lucrative draw for drug formulators in all therapy categories. Susan Birks reports on market progress and predicted growth in the various categories

Drug Delivery

BASF completes €270m sale of custom synthesis business to Siegfried Holding

Deal includes parts of BASF's active pharmaceutical ingredients business

Europe | Finance | Information Technology

Advancing controlled release: from polymers to inorganics

Advanced drug delivery systems that provide improved control over active ingredient release have become a focus for research. Aia Malik and Mark Cresswell, from Lucideon, explore the use of polymers and inorganic materials for advanced controlled release systems

Drug Delivery

In the Press